Contract facts
NONENo full NAICS 325412 intel page yet. Browse NAICS intelligence
RADIOPHARMACEUTICALS- WBAMC. is a federal NONE award for W40m Mrc0 West held by Curium Us LLC. Estimated value $251K ($251K obligated). Current period of performance ends Sep 30, 2026. Last award drew 1 bidder. Place of performance: FORT BLISS TX.
Recompete timing
PublicCurrent PoP ends Sep 30, 2026 (40 days remaining). Agencies typically plan 12–18 months ahead — at 1.3 months out, that window is already open. The buying decision is likely already in motion.
Incumbent footprint
Public recordCurium Us LLC — $1.8M obligated across 17 awards (firm-wide, all agencies) · lead buyer Department of Defense (DOD).
Related awards
Same incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract W81K0025PA278?
W81K0025PA278 (Radiopharmaceuticals- WBAMC) is a W40m Mrc0 West award with a potential value of $251K, currently held by Curium Us LLC. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
Which office awarded W81K0025PA278?
W40m Mrc0 West awarded W81K0025PA278 to Curium Us LLC (potential $251K).
Who is the incumbent on W81K0025PA278?
Curium Us LLC is the incumbent with $1.8M across 17 related awards in SCOUT’s public footprint. The current period of performance ends Sep 30, 2026.
When does Curium Us LLC’s W81K0025PA278 come up for recompete?
SCOUT tracks a period-of-performance end of Sep 30, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.
